img1.jpg

Lipidomics for personalized medicine

BIOMARKER DISCOVERY AND LIPIDOMIC SERVICES

Zora biomarkers will enable personalized medicine from early stage biomarkers to full fledged companion diagnostics. Zora has developed multiple platforms for molecular lipid quantification in high throughput. These lipid based data will make a valuable contribution to basic science and drug R&D. Lipids are most readily associated with metabolic diseases such as atherosclerosis or diabetes. Indeed, our work has centered on such studies and we have carried out work on vascular plaque lipidomics, lipoprotein composition and function as well as on translational models. However, lipidomics is equally applicable to other therapy areas such as CNS, oncology and inflammation among many.

Lipidomics can add another important dimension to your studies. Importantly, lipidomics can be used for biomarker discovery and development. Lipids can be used as disease biomarkers or they may function as specific drug response markers and serve as a gauge of efficacy or safety. 

BIOMARKER DISCOVERY & DEVELOPMENT

LIPIDOMIC SERVICES

  • MECHANISM OF ACTION
  • DOSE RESPONSE
  • TOXICOLOGICAL STUDIES
  • TARGET VALIDATION
  • TARGET DISCOVERY
  • COMPOUND SELECTION
  • DRUG COMPOUND QUANTIFICATION
  • TRANSLATIONAL STUDIES